1 September 2024 in American Journal of Physiology-Heart and Circulatory Physiology
LSLyndsey E. Shorey-Kendrick
Lyndsey E. Shorey-Kendrick
Prenatal cannabis use is increasing and despite the public health relevance, there is limited safety data regarding its impact on offspring cardiovascular health outcomes. We used a translational, nonhuman primate model of daily edible Δ-9-tetrahydrocannabinol (THC) consumption during pregnancy to assess its effects on the fetal cardiovascular system. THC-exposed fetal vascular tissues displayed upregulation of genes involved in cellular metabolism and inflammation, suggesting that prenatal THC exposure may impact fetal vascular tissues.
1 August 2024 in Bioactive Materials
Biodegradable metals offer a promising means to ameliorate many of the long-term risks associated with vascular devices made of conventional biostable stent metals. While numerous biodegradable metal alloys have been developed and characterized in animal models, knowledge of their blood reactivity and thrombogenicity remains unknown. Metal hemocompatibility is particularly valuable because current generation drug-eluting stents pose a significant long-term thrombosis risk. In this study, four pure metals, widely used as degradable base materials (Fe, Zn, Mg, and Mo), and three alloys commonly used in cardiovascular devices [NiTi, CoCr, and stainless steel (SS)] were evaluated. This work examined how each of these metals activate platelets, coagulation factors, and inflammation using in vitro hemocompatibility assays and a clinically relevant ex vivo non-human primate arteriovenous shunt model. Testing found that while all metals promoted a downstream activation of platelets and coagulation in flowing whole blood, platelet and fibrin attachment to Mg was markedly reduced. Additionally, Fe and Mo trended toward higher platelet attachment and contact pathway activation. Overall, the results suggest that Mg may delay clot initiation, but not eliminate clot formation, indicating the importance of understanding thrombosis in Mg alloys that are currently being developed for clinical use as biodegradable stents.
1 January 2020 in SSRN Electronic Journal
Background: Senescent cells accumulate in tissues over time as part of the natural aging process and the removal of senescent cells has shown promise for alleviating many different age-related diseases in mice. Cancer is an age-associated disease and there are numerous mechanisms driving cellular senescence in cancer that can be detrimental to recovery. Thus, it would be beneficial to eliminate senescent cancer cells to prevent cancer recurrence or progression. Methods: We used molecular modeling to develop a series of rationally designed peptides to mimic and target FOXO4 disrupting the FOXO4-TP53 interaction and releasing TP53 to induce apoptosis. We then tested these peptides as senolytic agents for the elimination of senescent cancer cells both in cell culture and in vivo. Findings: Here we show that these peptides can act as senolytics for eliminating senescent human cancer cells both in cell culture and in orthotopic mouse models. We then further characterized one peptide, ES2, showing that it co-localizes with FOXO4 foci and binds FOXO4 to a greater extent compared to TP53. Finally, we show that concomitant intra-tumoral injection of ES2 plus a BRAF inhibitor results in a significant increase in apoptosis in a transgenic mouse model of melanoma. Interpretation: Taken together, our results reveal that peptides can be generated to specifically eliminate FOXO4+ senescent cancer cells, which has implications for eradicating residual disease and as a combination therapy for frontline treatment of cancer. Funding Statement: This work was supported by the Cancer Early Detection Advanced Research Center at Oregon Health & Science University. Declaration of Interests: S.S. Cinaroglu, Y. Ahiska, U. Sezerman, G.B. Akcapinar, E. Timucin have a patent for the ES2 structure and are members of a company, Eternans Ltd. that is working on ES2 for therapeutic use. No potential conflicts of interest were disclosed by the other authors. Ethics Approval Statement: All experiments were approved by Oregon Health and Science University (OHSU) Institutional Animal Care and Use Committee (IACUC) (TR01_IP00000674) and conformed to the guidelines set by United States Animal Welfare Act and the National Institutes of Health.
18 March 2026 in Acta Biomaterialia
Vascular occlusions are a major cause of cardiovascular disease and require interventions including graft bypass surgery; yet, the development of synthetic vascular grafts remains a challenge due to the inability of synthetic biomaterials to support an anti-immunogenic endothelium. Topographical micropatterning of biophysical cues offers a promising strategy to enhance graft endothelialization. As the interface between the biomaterial and blood, endothelial cells provide a bioactive interface which regulates inflammation. We utilized topographical micropatterning of polyurethane biomaterial to induce endothelial cell elongation and alignment and measured the resultant transcriptional changes using bulk RNA-sequencing. Cell phenotype was characterized by gene and protein expression as well as chemokine secretion. The biomaterial micropatterning-modulated elongated and aligned morphology promoted an anti-inflammatory transcriptome, reduced pro-inflammatory chemokine secretion, and induced the transcription coregulator yes-associated protein (YAP) phosphorylation, supporting the anti-immunogenic properties of endothelial cells. Cytoskeletal regulation of this anti-immunogenic phenotype was quantified through measurement of intermediate filament vimentin regulation of YAP localization and endothelial pro-immunogenic gene expression. Aggregation of vimentin was positively correlated with YAP dephosphorylation and suppressed proinflammatory gene expression, indicating that endothelial elongation and alignment influence gene regulation and cellular function independent of vimentin-mediated mechanisms. The ability of micropatterned endothelial cells to maintain their anti-immunogenic functions under pro-inflammatory conditions was demonstrated by the increased phosphorylation of YAP and decrease in pro-inflammatory IL-8 release. Our study highlights the potential of biomaterial cues to regulate endothelial cell behavior for vascular graft design. STATEMENT OF SIGNIFICANCE: We used topographical micropatterning to separate the role of endothelial monolayer morphology from unidirectional blood flow and test how architecture alone regulates gene programs. Micropatterned substrates produced a reproducibly elongated, aligned endothelium with coordinated modeling of the vimentin intermediate filament network. Bulk transcriptomics revealed a distinct morphology-associated expression state, including reduced inflammatory signaling and altered secretory profiles, alongside shifts in mechanosensitive regulatory programs and downstream transcriptional signatures. Together, these findings link cytoskeletal organization to endothelial mechanotransduction and highlight biomaterial topography as a design lever to tune endothelial function for preclinical and clinical applications.